LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Respiratory Pathogen Diagnostic Panel Now Certified for Use in Europe

By LabMedica International staff writers
Posted on 04 Nov 2015
European certification (CE marking) has been granted for a diagnostic panel that incorporates tests for 21 clinically-relevant viral and bacterial respiratory pathogens into a single closed microtiter plate well.

The wide range of the Luminex Corporation (Austin, TX, USA) NxTAG Respiratory Pathogen Panel also includes such atypical bacteria as Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila.

Image: The NxTAG Respiratory Pathogen Panel simultaneously detects 21 respiratory pathogens in a single closed tube system (Photo courtesy of Luminex Corporation).
Image: The NxTAG Respiratory Pathogen Panel simultaneously detects 21 respiratory pathogens in a single closed tube system (Photo courtesy of Luminex Corporation).

The NxTAG panel was designed for use with the Luminex MAGPIX instrument, which operates with fluorescent markers and magnetic microbeads. Each sample to be tested requires only minutes of hands-on time with no upstream reagent preparation. Simplified workflow allows extracted samples to be added directly to pre-plated, lyophilized reagents. The wells are then sealed and ready for closed tube amplification and subsequent detection using the Luminex MAGPIX instrument. Innovative tube strip design offers laboratories the flexibility to manage variable sample demand by processing a single sample or up to as many as 96 samples per run, without wasting consumables or reagents, or the need to have full batches. Total turnaround time is just over three hours for 96 samples.

Onboard SYNCT Software provides a comprehensive approach to data analysis and reporting, and enables the NxTAG Respiratory Pathogen Panel to integrate easily into any laboratory setting.

"As a leader in multiplexed solutions, we are excited to launch the next generation NxTAG Respiratory Pathogen Panel which delivers expanded coverage and a simple closed tube workflow, combined with the throughput and quality of results established by the xTAG Respiratory Viral Panel," said Thomas Pracht, Managing Director, EMEIA (Europe, Middle East, India, and Africa), at Luminex Corporation. "With the CE-IVD marking of the NxTAG Respiratory Pathogen Panel, we continue to focus on delivering solutions that address our customers' productivity needs."

Related Links:
Luminex Corporation


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Portable POCT Blood Gas Analyzer
BD100
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma

Latest Microbiology News

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample
03 Nov 2015  |   Microbiology

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens
03 Nov 2015  |   Microbiology

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures
03 Nov 2015  |   Microbiology